Susquehanna International Group’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $329K | Sell |
10,200
-900
| -8% | -$33.3K | ﹤0.01% | 10675 |
|
|
2025
Q4 | $467K | Buy |
11,100
+2,500
| +29% | +$101K | ﹤0.01% | 8942 |
|
|
2025
Q3 | $295K | Buy |
+8,600
| New | +$247K | ﹤0.01% | 10143 |
|
|
2025
Q2 | – | Sell |
-13,500
| Closed | -$400K | – | 13779 |
|
|
2025
Q1 | $400K | Sell |
13,500
-51,300
| -79% | -$1.96M | ﹤0.01% | 9395 |
|
|
2024
Q4 | $2.57M | Buy |
64,800
+38,800
| +149% | +$1.47M | ﹤0.01% | 4766 |
|
|
2024
Q3 | $885K | Buy |
26,000
+6,900
| +36% | +$194K | ﹤0.01% | 7081 |
|
|
2024
Q2 | $414K | Sell |
19,100
-15,200
| -44% | -$320K | ﹤0.01% | 8725 |
|
|
2024
Q1 | $760K | Sell |
34,300
-11,200
| -25% | -$273K | ﹤0.01% | 7522 |
|
|
2023
Q4 | $1.25M | Sell |
45,500
-700
| -2% | -$16.9K | ﹤0.01% | 6435 |
|
|
2023
Q3 | $1.03M | Buy |
+46,200
| New | +$1.19M | ﹤0.01% | 6565 |
|
|
2023
Q2 | – | Sell |
-15,900
| Closed | -$355K | – | 13208 |
|
|
2023
Q1 | $355K | Buy |
15,900
+800
| +5% | +$19.3K | ﹤0.01% | 9345 |
|
|
2022
Q4 | $358K | Sell |
15,100
-37,600
| -71% | -$874K | ﹤0.01% | 8668 |
|
|
2022
Q3 | $875K | Buy |
52,700
+31,300
| +146% | +$704K | ﹤0.01% | 6985 |
|
|
2022
Q2 | $426K | Buy |
21,400
+8,400
| +65% | +$170K | ﹤0.01% | 8662 |
|
|
2022
Q1 | $358K | Buy |
+13,000
| New | +$372K | ﹤0.01% | 9835 |
|
|
2021
Q4 | – | Sell |
-6,900
| Closed | -$321K | – | 13966 |
|
|
2021
Q3 | $321K | Sell |
6,900
-2,800
| -29% | -$122K | ﹤0.01% | 10453 |
|
|
2021
Q2 | $388K | Buy |
9,700
+800
| +9% | +$34.2K | ﹤0.01% | 10210 |
|
|
2021
Q1 | $478K | Sell |
8,900
-1,900
| -18% | -$109K | ﹤0.01% | 9586 |
|
|
2020
Q4 | $529K | Buy |
10,800
+1,300
| +14% | +$60.2K | ﹤0.01% | 8166 |
|
|
2020
Q3 | $309K | Sell |
9,500
-3,600
| -27% | -$114K | ﹤0.01% | 8643 |
|
|
2020
Q2 | $339K | Sell |
13,100
-2,500
| -16% | -$62.3K | ﹤0.01% | 8143 |
|
|
2020
Q1 | $379K | Sell |
15,600
-2,200
| -12% | -$55.4K | ﹤0.01% | 7522 |
|
|
2019
Q4 | $497K | Sell |
17,800
-11,900
| -40% | -$308K | ﹤0.01% | 6994 |
|
|
2019
Q3 | $713K | Buy |
29,700
+7,600
| +34% | +$202K | ﹤0.01% | 6487 |
|
|
2019
Q2 | $630K | Sell |
22,100
-2,900
| -12% | -$72.4K | ﹤0.01% | 6771 |
|
|
2019
Q1 | $626K | Buy |
+25,000
| New | +$477K | ﹤0.01% | 5872 |
|
|
2018
Q4 | – | Sell |
-22,200
| Closed | -$212K | – | 10036 |
|
|
2018
Q3 | $212K | Buy |
+22,200
| New | +$245K | ﹤0.01% | 8113 |
|
|
2017
Q2 | – | Sell |
-12,300
| Closed | -$113K | – | 9884 |
|
|
2017
Q1 | $113K | Buy |
+12,300
| New | +$101K | ﹤0.01% | 8338 |
|
Other funds holding VCYT
VPM
VCM
AIM
Susquehanna International Group's VCYT Position: Q1 2026 in Review
Susquehanna International Group increased its Veracyte (VCYT) stake by 218% in Q1 2026, buying an estimated $1.91M and bringing the position to 75,258 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #5728.
Susquehanna International Group first reported a position in VCYT in Q1 2016 and has held it in 37 quarters since. The position peaked at $16.5M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Susquehanna International Group held 75,258 shares of Veracyte worth $2.42M as of Q1 2026.
- Susquehanna International Group bought 51,590 Veracyte shares in Q1 2026, an estimated $1.91M.
- Veracyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5728 holding.
- Susquehanna International Group first reported a position in Veracyte in Q1 2016 and has held it in 37 quarters since.
- Susquehanna International Group's Veracyte position peaked at $16.5M in Q2 2025.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.